WuXi Biologics (Cayman)
Stock Forecast, Prediction & Price Target
WuXi Biologics (Cayman) Financial Estimates
WuXi Biologics (Cayman) Revenue Estimates
WuXi Biologics (Cayman) EBITDA Estimates
WuXi Biologics (Cayman) Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $10.29B N/A | $15.26B 48.38% | $17.03B 11.56% | Avg: $20.67B Low: $20.67B High: $20.67B avg. 21.34% | Avg: $23.68B Low: $23.68B High: $23.68B avg. 14.60% | Avg: $22.76B Low: $22.76B High: $22.76B avg. -3.89% | Avg: $20.92B Low: $20.92B High: $20.92B avg. -8.06% |
Net Income
% change YoY
| $3.38B N/A | $4.42B 30.45% | $3.39B -23.08% | Avg: $9.46B Low: $9.46B High: $9.46B avg. 178.41% | Avg: $11.07B Low: $11.07B High: $11.07B avg. 16.95% | Avg: $12.01B Low: $12.01B High: $12.01B avg. 8.49% | Avg: $21.50B Low: $21.50B High: $21.50B avg. 79.02% |
EBITDA
% change YoY
| $3.62B N/A | $5.06B 39.93% | $5.50B 8.53% | Avg: $6.70B Low: $6.70B High: $6.70B avg. 21.80% | Avg: $7.68B Low: $7.68B High: $7.68B avg. 14.60% | Avg: $7.38B Low: $7.38B High: $7.38B avg. -3.89% | Avg: $6.78B Low: $6.78B High: $6.78B avg. -8.06% |
EPS
% change YoY
| $0.81 N/A | $1.06 30.86% | $0.77 -27.35% | Avg: $2.18 Low: $2.18 High: $2.18 avg. 182.65% | Avg: $2.55 Low: $2.55 High: $2.55 avg. 16.95% | Avg: $2.76 Low: $2.76 High: $2.76 avg. 8.49% | Avg: $4.94 Low: $4.94 High: $4.94 avg. 79.02% |
Operating Expenses
% change YoY
| $854.61M N/A | $1.41B 65.88% | $2.87B 103.04% | Avg: $2.34B Low: $2.34B High: $2.34B avg. -18.44% | Avg: $2.69B Low: $2.69B High: $2.69B avg. 14.60% | Avg: $2.58B Low: $2.58B High: $2.58B avg. -3.89% | Avg: $2.37B Low: $2.37B High: $2.37B avg. -8.06% |
FAQ
What is WuXi Biologics (Cayman) stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 70.72% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is 9.46B, average is 9.46B and high is 9.46B.
What is WuXi Biologics (Cayman) stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 5.99% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $20.67B, average is $20.67B and high is $20.67B.
What is WuXi Biologics (Cayman) stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 71.78% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is $2.18, average is $2.18 and high is $2.17.